LUCIANA ARCAS: Open Payments
NPI 1902237613 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 35 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $384 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $141 |
| ABBVIE INC. | 5 | $100 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| PFIZER INC. | 3 | $74 |
| ViiV Healthcare Company | 3 | $65 |
| Lilly USA, LLC | 2 | $59 |
| Teva Pharmaceuticals USA, Inc. | 1 | $44 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Dexcom, Inc. | 1 | $28 |
| Novo Nordisk Inc | 1 | $25 |
Products named: EVENITY, SHINGRIX, MOUNJARO, ELIQUIS, QULIPTA, UBRELVY, AUSTEDO XR, AIRSUPRA.
Industry payments across OR — which companies pay providers there.
